Difference between revisions of "Short answer questions submitted by Tate"

Jump to navigation Jump to search

Short answer questions submitted by Tate (view source)

Revision as of 13:28, 12 August 2015

1,094 bytes removed ,  13:28, 12 August 2015
no edit summary
Line 17: Line 17:
==[[CAP Molecular Diagnosis of Lung Cancer]]==
==[[CAP Molecular Diagnosis of Lung Cancer]]==


===CAP Molecular Diagnosis of AML===
==[[CAP Molecular Diagnosis of AML]]==
 
{{hidden|List 6 genes associated with Acute Myeloid Leukemia that have been identified by cloning translocation break points|RUNX1, RUNX1T1, PML, CBFB, ETV6, MLL}}
 
{{hidden|List the 5 main categories of classification of Acute Myeloid Leukemia|1. AML with recurrent genetic abnormalities, 2. AML with myelodysplasia-related changes, 3. Therapy related myeloid neoplasms, 4. AML, NOS, 5. Myeloid sarcoma}}
 
{{hidden|Give any three translocations identified in AML.|t(8,21), inv (16), t(15,17), t(9,11), t(6,9), inv(3), t(1,22), mutated NPM1, mutated CEBPA}}
 
{{hidden|What entities are fall under the AML, NOS classification?|AML with minimal differentiation, AML without maturation, AML with maturation, Acute myelomonocytic leukemia, Acute monoblastic/monocytic leukemia, Acute erythroid leukemias (pure erythroid, erythroleukemia, erythroid/myeloid), Acute Megakaryoblastic leukemia, Acute basophilic leukemia, Acte panmyelosis with myelofibrosis}}
 
{{hidden|List 2 genes which confer a poor prognostic impact vs 2 which confer a good prognostic impact.|Poor: KIT, FLT3, Good: NPM1, CEBPA}}
 


=== CAP Breast Cancer and Molecular ===
=== CAP Breast Cancer and Molecular ===
Tate
Account-creators
99

edits

Retrieved from "https://librepathology.org/wiki/Special:MobileDiff/39157"

Navigation menu